Last checked at 20 Feb 2020 11:12
Tristel plc
("Tristel" or the "Company")
Issue of Equity
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that, further to the announcement of 18 February 2020 regarding the exercise of options by certain employees, application has been made for the 109,500 new Ordinary Shares issued to be admitted to trading on AIM and dealings are now expected to commence on 24 February 2020, not 21 February as originally anticipated.
The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following the exercise of options, the Company's issued share capital consists of 44,921,823 Ordinary Shares. Accordingly, the figure of 44,921,823 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information please contact:
Tristel plc | Tel: 01638 721 500 |
Paul Swinney, Chief Executive Officer | |
Liz Dixon, Finance Director | |
Walbrook PR Ltd | Tel: 020 7933 8780 or tristel@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07854 391 303 |
finnCap | Tel: 020 7220 0500 |
Geoff Nash / Giles Rolls, Corporate Finance | |
Alice Lane, ECM |
|